Valmore Holding Sae

Valmore Holding Sae maintains a debt-to-equity ratio of 1.39, indicating a moderate reliance on debt financing, while its liquidity position is characterized as medium. The company holds $60.7 million in cash and equivalents, but this is offset by $712.4 million in long-term debt, resulting in a net cash position that is negative. The current ratio of 2.09 suggests the company has sufficient short-term assets to cover its short-term liabilities, supporting a stable working capital position.

Profitability metrics show a return on equity (ROE) of 31.54% and a return on assets (ROA) of 10.07%, both of which exceed the typical thresholds for the Diversified Chemicals industry. The operating margin, calculated as operating income of $273.3 million on revenue of $684.9 million, stands at 40.0%, which is significantly higher than the industry median, indicating strong operational efficiency.

The company's revenue is not segmented by product or geography in the available data, but its exposure to geographic markets is not explicitly detailed. Given the nature of the Diversified Chemicals industry, it is likely that Valmore serves multiple regions, though the extent of geographic diversification remains unclear.

Looking ahead, the company is projected to maintain a stable revenue trajectory, with no significant growth or contraction expected in the next fiscal year. The current fiscal year revenue of $684.9 million reflects a consistent performance, and the absence of a clear growth driver or decline factor suggests a steady-state operating model.

Risk factors include a medium liquidity risk due to the company's reliance on long-term debt and the potential for interest rate volatility to impact borrowing costs. The risk assessment also notes a low dilution risk, as the number of shares outstanding has not changed between basic and diluted figures, indicating no imminent share issuance or dilution pressure.

Recent events include analyst price targets ranging from $0.95 to $1.70, with a mean of $1.28 and a median of $1.20. Analysts have issued two "Buy" recommendations and no "Strong Buy" or "Hold" ratings, suggesting a cautiously optimistic outlook on the company's valuation and performance.